ARTICLE | Clinical News
SuperGen regulatory update
May 28, 1996 7:00 AM UTC
SUPG received Orphan Drug designation for its RF1051 obesity pill to treat Prader-Willi Syndrome (PWS), a chronic genetic disease characterized by extreme obesity, short stature and mental retardation...